← All organizations

Molecular Targeting Technologies, Inc.

For profitWebsite ↗

Also known as: Molecular Targeting Technologies, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jun 18, 2022

Timeline

2000s

Dec 1, 2001
Molecular Targeting Technologies, Inc.— Founded

Drugs by trial phase (4 distinct, 3 trials)

Phase 2 (1 own, 0 via acquisition)

99mtc-glucarate

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (3)

NCT05475210Lead sponsorPhase 1Jun 18, 2022
NCT05177640CollaboratorPhase 1Jun 17, 2021
NCT00614354Lead sponsorPhase 2Oct 1, 2008

Details

Founded: West Chester, PA, US Dec 1, 2001
Last known activity: Jun 18, 2022

Notes

CRO